Ever-busy global pharmaceutical company Bristol Myers Squibb (NYSE: BMY) had quite an active February. Since much of the news ...

Akeso (SEHK:9926) reported long term survival data from a Phase II study of cadonilimab in advanced cervical cancer, highlighting durable benefits in a setting with limited treatment options. The ...

Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Antonio Ocejo, MD, discusses supportive care implications from new data comparing ipilimumab/nivolumab in older vs younger ...

Many cancer treatments were developed for adult physiology, not pediatric biology, resulting in disproportionate long-term ...

Iron is essential to biological function, and iron-based nanomaterials may become valuable tools in the long-term effort to ...

Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, has sponsored PanCAN PurpleStride for ...

Statista, a global data company that publishes insights for 170 industries, projects four cancer therapies will be among the top 10 best-selling pharmaceutical products in the U.S. this year.  The ...

Cells in our immune system are best known for providing security against external invaders such as bacteria and viruses. These immune cells also guard against internal threats, including cancerous ...

Long-term results from a phase 2 study presented at the 27th European Congress on Gynaecological Oncology (ESGO 2026) in Hong ...

But the FDA’s decision does not preclude CMS from determining that the higher dose is not reasonable and necessary — ...